 There's a clinical trial getting underway to test a drug taken by many longevity enthusiasts. NPR's Alison Opry explains the study will evaluate whether the drug rapamycin can slow age-related gum disease. Millions of people have gum disease, and age is a leading risk factor. The condition is linked to higher risk of heart disease and perhaps dementia, too.